Topic Teaching: Hemolytic Disease of the Fetus and Newborn

Dr. Gwen Clarke
Associate Medical Director, Donor & Clinic Services

 

• Understand the definition and pathogenesis of HDF
• Learn the testing strategy and goals of perinatal serological testing
• Gain awareness of some forthcoming changes to the way we prevent and treat HDFN

• Guidelines for blood grouping and red cell antibody testing in pregnancy. White, Qureshi, Massey, Needs, Byrne, Daniels, Allard, and the BCSH. Transfusion Medicine, 2016, 26, 246-263 (available at: http://www.b-s-h.org.uk/guidelines/guidelines/blood-grouping-and-antibody-testing-in-pregnancy/) 
• The management of women with red cell antibodies during pregnancy. Green Top Guidelines no. 65 (available at: https://www.rcog.org.uk/en/guidelines-research-services/guidelines/gtg65/)
• Hemolytic disease of the fetus and newborn. M De Haas, FF Thurik, JM Koelewijn, CE Van der Schoot. Vox Sanguinis (2015) 109 99-113
• SOGC Clinical Practice Guidelines: Routine non-invasice prenatal prediction of fetal RHD genotype in Canada: The time is here. Johnson, Macdonald, Clarke and Skoll. J Obstet Gynaecol Can 2017; 39(5): 366-373.

The session is a self-approved group learning activity (Section1) as defined by the Maintenance of Certification program of the Royal College of Physicians and Surgeons of Canada. The LearnTransfusion series is the seminar component of the Areas of Focused Competency (AFC)-Diploma Program in Transfusion Medicine. The series, organized by Canadian Blood Services is also open to all practitioners in the field of Transfusion Medicine. Through a series of regular webinars, trainees and practitioners are exposed to various scientific, technical and clinical aspects of transfusion medicine. For more information about the LearnTransfusion series and how to register visit LearnTransfusion series.